SCHEMBL18179071

SCHEMBL18179071

CCOC(=O)C(C)C(=O)C(=O)OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.42
HPGD P15428 1/20 0.42
MGAM O43451 1/20 0.41
GAA P10253 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
HSD17B10 Q99714 2/20 0.37
LMNA P02545 1/20 0.37
ALOX15 P16050 3/20 0.36
CYP3A4 P08684 2/20 0.36
TSHR P16473 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
SOAT1 P35610 1/20 0.36
EGLN1 Q9GZT9 1/20 0.35
CHRM1 P11229 1/20 0.35
ADORA1 P30542 1/20 0.35
MAPT P10636 1/20 0.34
CAD P27708 1/20 0.34
MMP8 P22894 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL60410 0.86 ALDH1A1 (0.42) ALDH1A1HPGDMGAMGAASI
SCHEMBL5143818 0.81 SMN1; SMN2 (0.42) ALDH1A1TSHREGLN1MMP8SMN1; SMN2
SCHEMBL7278815 0.81 ALDH1A1 (0.41) ALDH1A1HPGDMGAMGAASI
SCHEMBL4658427 0.79 MGAM (0.46) ALDH1A1HPGDMGAMGAASI
Ammonia Solution, Strong SCHEMBL11065656 0.79 MGAM (0.46) ALDH1A1HPGDMGAMGAASI
SCHEMBL5145196 0.78 ALDH1A1 (0.39) ALDH1A1HPGDMGAMGAASI
SCHEMBL141446 0.78 ALDH1A1 (0.53) ALDH1A1HPGDMGAMGAASI
SCHEMBL6049861 0.77 ALDH1A1 (0.42) ALDH1A1HPGDMGAMGAASI
SCHEMBL28379724 0.77 MGAM (0.39) ALDH1A1MGAMGAASIMGAM2
SCHEMBL7574321 0.77 GAA (0.39) ALDH1A1MGAMGAASIMGAM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160311826-A1 SGC STIMULATORS CYCLERION THERAPEUTICS, INC. 2016-10-27 US disclosed
US-20160311826-A1 SGC STIMULATORS CYCLERION THERAPEUTICS, INC. 2016-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311826-A1 SGC STIMULATORS GUCY1A1, GUCY1B1, GUCY1A2 ALDH1A1 2205/4885HPGD 99/4885MGAM 3490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.